Genmab — Oktober 2022
-
Merus presented first data on their EGFR and c-MET bispecific ; judging solely from the stock price reaction , -17%, it doesn't seem to be a competitor for Amivantamab... https://ir.merus.nl/news-releases/news-release-details/merus-presents-first-human-data-mcla-129-34th-eortcnciaacr-ena
-
2900 i luk må vente til i morgen:-)
-
Exelixis also presented data on their TF ADC and probably not that impressive so far ....https://ir.exelixis.com/news-releases/news-release-details/exelixis-announces-promising-initial-dose-escalation-results
-
Godmorgen
-
Torsdagens aviser med Carlsberg, Vestas og Ringkjøbing Landbobank https://www.proinvestor.com/investornyt/895916/torsdagens-aviser-med-carlsberg-vestas-og-ringkjobing-landbobank
-
Dagens Finanskalender: https://www.proinvestor.com/finanskalender
-
Godmorgen. Udokumenterede rygter siger, at Nordea over natten er rekapitaliseret ved tvangssalg af kunders aktiedepoter og missionen skulle være vellykket. Et klassisk bank run er undgået.
-
-
Kort video - Der blæser milde vinde over aktiemarkederne denne uge, hvor de danske aktier er steget med 10% og ligger i førerfeltet af verdens aktier ift. stigninger i oktober. Men er det holdbare stigninger? Omtalte selskaber denne uge er bl.a. Anavex. Genmab, Zealand Pharma og Bavarian Nordic. Slutteligt kommer Helge Larsen med en opdatering på laksesektoren i Norge - er regeringen ved at få kolde fødder på deres forslag om grundrenteskat? https://www.proinvestor.com/boards/10733
-
Det blev gåsevin?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind